HCA Healthcare, Inc. (NYSE:HCA) Holdings Increased by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 25.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 25,000 shares of the company's stock after acquiring an additional 5,000 shares during the quarter. HCA Healthcare makes up 4.7% of Sivik Global Healthcare LLC's portfolio, making the stock its 4th biggest holding. Sivik Global Healthcare LLC's holdings in HCA Healthcare were worth $8,639,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Atwood & Palmer Inc. purchased a new position in shares of HCA Healthcare in the 1st quarter worth $28,000. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at approximately $31,000. ORG Partners LLC lifted its holdings in HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after buying an additional 86 shares in the last quarter. Tidemark LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at approximately $36,000. Finally, Legacy Investment Solutions LLC raised its holdings in HCA Healthcare by 99.0% in the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after acquiring an additional 95 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HCA has been the topic of a number of research reports. Guggenheim began coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Barclays set a $416.00 price objective on HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Robert W. Baird reissued a "neutral" rating and set a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Finally, Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Seven analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus target price of $394.33.

HCA Healthcare Stock Up 0.1%

Shares of HCA Healthcare stock traded up $0.34 during trading on Tuesday, reaching $379.06. The stock had a trading volume of 1,103,292 shares, compared to its average volume of 1,469,725. The company has a market capitalization of $91.19 billion, a price-to-earnings ratio of 16.85, a P/E/G ratio of 1.31 and a beta of 1.49. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The stock has a fifty day moving average price of $363.06 and a two-hundred day moving average price of $335.36. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. During the same quarter last year, the business earned $5.36 EPS. The company's quarterly revenue was up 5.7% compared to the same quarter last year. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.